EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Optical genome mapping improves detection and characterisation of cytogenetic abnormalities in non‐Hodgkin lymphomas

Coura Fall, Agnès Daudignon iD, Séverine Valmary-Degano, Julie Mondet iD, Lucile Bussot, Lysiane Molina, Simon Chevalier, Edouard Bonneville iD, Pierre Aubert, Sylvie Tondeur, Clémentine Legrand, Jean-Baptiste Gaillard und 4 weitere

British Journal of Haematology · 2026-07 · 209 (1) · 31-41

DOI: 10.1111/bjh.70575 ↗

Kurz gefasst

Fachartikel in der Zeitschrift British Journal of Haematology, online erschienen am 24.05.2026. Verfasst von Coura Fall und 15 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biological Hematology, Hematological Genetics Unit, Grenoble Alpes University Hospital, Grenoble, France. Hauptthemen laut MEDLINE: Lymphoma, Non-Hodgkin, Chromosome Aberrations, Chromosome Mapping. Die Arbeit nennt 60 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Health Research and Innovation Grenoble, Association pour la Recherche sur les Affections Malignes en Immunologie Sanguine (ARAMIS).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Classical cytogenetics (CC) encompassing fluorescence in situ hybridisation (FISH) and karyotype remains central to the diagnostic work‐up of non‐Hodgkin lymphoma (NHL). However, karyotype is limited by restricted access to fresh tumour tissue and low resolution, while FISH provides targeted information. Optical genome mapping (OGM) has emerged as a genome‐wide, high‐resolution approach capable of detecting both translocations and copy number variations in a single assay. To assess its feasibility and diagnostic performance in routine practice, we prospectively compared OGM to CC in 105 patients with NHL. OGM was technically feasible in both fresh and frozen tissue specimens. Among 511 cytogenetic abnormalities (CAs) directly compared, 91.1% were concordant between the two methods. Using the low allele fraction guided assembly pipeline, OGM identified all 77 immunoglobulin loci rearrangements, with a sensitivity threshold of 5%. Overall, OGM detected diagnostically relevant CAs in 99/105 patients (94.2%). OGM outperformed CC in 10/105 patients (9.5%), revealing cryptic rearrangements involving major target genes ( MYC , BCL2 and BCL6 ) as well as diagnostically relevant CAs in cases with uncertain diagnoses or non‐informative karyotypes. In conclusion, OGM demonstrated feasibility in routine practice and superior diagnostic performance compared with CC, supporting its integration into the standard genetic work‐up of NHL.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Lymphoma, Non-HodgkinChromosome AberrationsChromosome MappingHumansFemaleIn Situ Hybridization, FluorescenceMaleMiddle AgedAgedAdultKaryotypingAged, 80 and over

Stichwörter der Autor:innen

FISHcytogeneticskaryotypenon‐Hodgkin lymphomaoptical genome mapping

Autor:innen und Institutionen

  • Department of Biological Hematology, Hematological Genetics Unit, Grenoble Alpes University Hospital, Grenoble, France.
  • Institute of Medical Genetics, Lille University Hospital, Lille, France.
  • Hematology and Immunology Laboratory, Valenciennes University Hospital, Valenciennes, France.
  • Department of Pathology, Grenoble Alpes University Hospital, Grenoble, France.
  • INSERM U1209, CNRS UMR 5309, Institute for Advanced Biosciences (IAB), University Grenoble Alpes, Grenoble, France.
  • Department of Clinical Hematology, Grenoble-Alpes University Hospital, Grenoble, France.

ORCID-Profile: Agnès Daudignon, Julie Mondet, Edouard Bonneville, Hélène Guermouche, Anouk Emadali, Christine Lefebvre

Förderung

  • Health Research and Innovation Grenoble
  • Association pour la Recherche sur les Affections Malignes en Immunologie Sanguine (ARAMIS)

Zitieren

APA

Fall, C., Daudignon, A., Valmary-Degano, S., Mondet, J., Bussot, L., Molina, L., Chevalier, S., Bonneville, E., Aubert, P., Tondeur, S., Legrand, C., Gaillard, J. B., Guermouche, H., Emadali, A., Carras, S., & Lefebvre, C. (2026). Optical genome mapping improves detection and characterisation of cytogenetic abnormalities in non‐Hodgkin lymphomas. British Journal of Haematology, 209(1), 31-41. https://doi.org/10.1111/bjh.70575

Vancouver

Fall C, Daudignon A, Valmary-Degano S, Mondet J, Bussot L, Molina L, et al. Optical genome mapping improves detection and characterisation of cytogenetic abnormalities in non‐Hodgkin lymphomas. British Journal of Haematology. 2026;209(1):31-41. doi:10.1111/bjh.70575

BibTeX
@article{Fall2026,
  author = {Fall, Coura and Daudignon, Agnès and Valmary-Degano, Séverine and Mondet, Julie and Bussot, Lucile and Molina, Lysiane and Chevalier, Simon and Bonneville, Edouard and Aubert, Pierre and Tondeur, Sylvie and Legrand, Clémentine and Gaillard, Jean-Baptiste and Guermouche, Hélène and Emadali, Anouk and Carras, Sylvain and Lefebvre, Christine},
  title = {Optical genome mapping improves detection and characterisation of cytogenetic abnormalities in non‐Hodgkin lymphomas},
  journal = {British Journal of Haematology},
  year = {2026},
  volume = {209},
  number = {1},
  pages = {31--41},
  doi = {10.1111/bjh.70575}
}
Kostenlos starten →